[China Lodging Group, Limited Announces Results of 2013 Annual General Meeting SHANGHAI, China, Nov. 13, 2013 (GLOBE NEWSWIRE) -- China Lodging Group, Limited (Nasdaq:HTHT) ("China Lodging Group" or the "Company"), a leading and fast-growing multi-brand hotel group in China, today announced that its 2013 annual general meeting of shareholders was held on November 13, 2013. During the meeting, the following]
[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]
[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2014 2Q14 New Subscribers Reached 15,928 2Q14 Revenue Up 10.3% YOY to RMB141.6 Million 2Q14 Operating Income Up 19.7% YOY to RMB56.3 Million Conference Call to be Held November 15, 2013 at 8:00 a.m. ET HONG KONG, China, November 14, 2013 -- China Cord]
[Biostar Pharmaceuticals, Inc. Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule BSPM XIANYANG, China, Nov. 13, 2013 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. ( Ronghua Wang, Biostar's Chairman, commenting on the announcement, stated: "We strongly believe that regaining compliance with NASDAQ's continued listing requirements is an important achievement for the Company. Having resolved this issue, we can continue focusing on]
[Contact for Media and Investors: Cassia Curran NetEase,Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports Third Quarter 2013 Unaudited Financial Results (Beijing November13, 2013) NetEase,Inc. (NASDAQ: NTES), one of Chinas leading Internet and online game services providers, today announced its unaudited financial results for the third quarter ended]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2014 2Q14 New Subscribers Reached 15,928 2Q14 Revenue Up 10.3% YOY to RMB141.6 Million 2Q14 Operating Income Up 19.7% YOY to RMB56.3 Million Conference Call to be Held November 15, 2013 at 8:00 a.m. ET HONG KONG, China, November 14, 2013 -- China Cord]
[Biostar Pharmaceuticals, Inc. Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule BSPM XIANYANG, China, Nov. 13, 2013 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. ( Ronghua Wang, Biostar's Chairman, commenting on the announcement, stated: "We strongly believe that regaining compliance with NASDAQ's continued listing requirements is an important achievement for the Company. Having resolved this issue, we can continue focusing on]
[QuickLinks -- Click here to rapidly navigate through this document NAME="da44004_yy_inc._announces_proposed_off__yy_02954"> YYINC. GUANGZHOU, CHINANovember14, 2013: YYInc. (NASDAQ: YY), a revolutionary richmmunication social platform ("YY" or the "Company"), today announced that it proposes to offer up to US$250million ingregate principal amount ofnvertible senior notes due 2018 (the"notes"), subject to marketnditions and other factors. Thempany intends to] [QuickLinks -- Click here to rapidly navigate through this document NAME="page_fa44004_1_1"> NAME="fa44004_yy_inc._index_to_unaudited_int__yy_03122"> YYInc. Page Interimndensednsolidated Financial Statements (unaudited) Unaudited Interimndensednsolidated Balance Sheets of December31, 2012 and September30, 2013 2 Unaudited Interimndensednsolidated Statements of Operations andmprehensiveome for the Nine Months Ended September30, 2012 and 2013] [QuickLinks -- Click here to rapidly navigate through this document NAME="page_ga44004_1_1"> Discussion of Selected Statements of Operations Items Revenues In the nine months ended September30, 2013, we primarily derived our revenues from internet value-added services, or IVAS, and onlinevertising. Our IVAS revenues are primarilymprised of revenues from the paying users of YYMusic, online games and,]
[] [CERTIFICATION I, An Fengbin, certify that: 1. 2. 3. 4. (a) (b) (c) (d) 5. (a) (b) An Fengbin An Fengbin President, Chief Executive Officer] [CERTIFICATION I, Wang Hao, certify that: 1. 2. 3. 4. (a) (b) (c) (d) 5. (a) (b) Wang Hao Wang Hao Chief Financial Officer] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. An Fengbin An Fengbin President, Chief Executive Officer] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. Wang Hao Wang Hao Chief Financial Officer]
